Singular Genomics Systems Inc expected to post a loss of 33  cents a share - Earnings Preview

Singular Genomics Systems

06/05/2022 23:13

* Singular Genomics Systems Inc  OMIC.OQ   OMIC.O  is
expected
to report results on May 10.
    * ​Refinitiv's mean analyst estimate for Singular Genomics
Systems
Inc is for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $15​, above​ its last closing price of $3.98. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.31       -0.31      -0.27     Beat    12.3
 Sep. 30 2021  -0.24       -0.24      -0.25     Missed  -4.2
 Jun. 30 2021  -0.20       -0.20      -0.43     Missed  -111.5
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated May 6 at 22:13 GMT.  All
figures in US dollars  unless otherwise stated